Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions

Ming‐Tain Lai(Leo Pharma (Australia)), Michael D. Miller(University of Connecticut)

Viruses

September 23, 2016

10.3390/v8100263

Cited by 18

Related Papers

Genome sequencing in microfabricated high-density picolitre reactors

|Nature|2005|7.7k

A Draft Sequence of the Neandertal Genome

|Science|2010|4.6k

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

|The Lancet|2009|620

Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

|Science|2004|284

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

|The Lancet HIV|2018|145